News | Digital Pathology | March 07, 2024

Digital and computational pathology solution provider Proscia has announced that Pramana, Inc., is now a Proscia Ready partner, in an alliance the companies report paves the way to advance cancer research and diagnosis with enriched, high-quality DICOM images.

Digital and computational pathology solution provider Proscia has announced that Pramana, Inc. is now a Proscia Ready partner, in an alliance the companies report paves the way to advance cancer research and diagnosis with enriched, high-quality DICOM images.

Digital and computational pathology solution provider Proscia has announced that Pramana, Inc. is now a Proscia Ready partner, in an alliance the companies report paves the way to advance cancer research and diagnosis with enriched, high-quality DICOM images. Image courtesy: Proscia


March 7, 2024 — Software company Proscia, a provider of digital and computational pathology solutions, has announced that Pramana, Inc., an AI-enabled health tech company, is now a Proscia Ready partner. Pramana, headquartered in Cambridge, MA, joins the partner alliance to help life sciences organizations and diagnostic laboratories increasingly leverage enriched, high-quality data, including DICOM images, in their routine research and clinical operations, according to a statement released by Philadelphia, PA-based Proscia.

Proscia Ready was established to help laboratories accelerate the scaled adoption of digital pathology with confidence. It delivers on this aim by offering the freedom to choose from established hardware and software solutions; Proscia’s Concentriq enterprise pathology platform is designed to integrate with partners’ technologies and incorporate them into the diverse workflows it drives. Through their partnership, Proscia and Pramana will work to integrate Pramana’s SpectralHT family of scanners with Concentriq, enabling laboratories to benefit from Pramana’s unique approach to whole slide imaging in daily practice.

“Pramana is expanding the potential of pathology data,” said Arun Ananth, Proscia’s Chief Commercial Officer. “It is empowering pathologists and scientists with richer images so that they can make more informed decisions and enabling them to capitalize on the standardization that DICOM provides. We are thrilled to welcome Pramana to Proscia Ready so that customers can increasingly realize these benefits.”

Pramana’s SpectralHT family of scanners provides automatic quality assessment and image enrichment with valuable metadata, all in a standardized DICOM format. The company’s in-line quality assurance module delivers whole slide images with the highest rate of first-pass success while also storing critical information that can help identify areas for improvement in lab practices for sample preparation.

“Our SpectralHT family of scanners continues to gain traction because of the enriched, high-quality images that they create at scale,” said Mike Koenig, Pramana’s Chief Business Officer. “Joining Proscia Ready was an easy decision for us. The partners understand all that laboratories need to maximize the value of this data, paving the way to accelerate research and diagnosis.”

Proscia Ready is an alliance of solution providers helping laboratories to confidently grow their use of digital pathology. As scaling digital pathology adoption requires a broad portfolio of hardware and software solutions, the partners offer a comprehensive approach that enables laboratories to overcome the complexities of working with multiple vendors. This starts with a commitment to interoperability and extends to joint support agreements and a shared vision to guide future innovation.

Proscia is a software company accelerating the transformation to digital pathology, which reports that its Concentriq enterprise pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline.

For its part, Pramana, Inc. is a health-tech company founded by nference, inc., enabling seamless digital pathology adoption by pathology labs and medical centers. Built upon extensive industry experience and patented technological innovation, Pramana is a gateway for pathologists and physicians to utilize AI-enabled decision support.

Both companies will be participating in the upcoming United States and Canadian Academy of Pathology 113th Annual Meeting, USCAP 2024, being held March 23-28 in Baltimore, MD.

More information, visit www.proscia.com, www.pramana.ai


Related Content

News | Digital Pathology

July 24, 2024 — Proscia, a developer of artificial intelligence (AI)-enabled digital pathology solutions for precision ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | Radiology Education

July 19, 2024 — Core tactics to address the current medical imaging and radiation therapy workforce shortage and build ...

Time July 19, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 11, 2024 — Artificial Intelligence (AI) tools can play a key role in medical imaging if radiologists trust in their ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
Feature | Women's Health | By Jordan Bazinsky

Investing in women’s health should not merely be a metric on the equity dashboard — it should drive policy and tactical ...

Time July 08, 2024
arrow
Subscribe Now